Showing results (371-380 of 579) with videos related to
Sort By:
Pageof 58
The Journal of Allergy and Clinical Immunology|August 3, 2023
The role of Janus kinase signaling in the pathology of atopic dermatitisEmma Guttman-Yassky, Alan D Irvine, Patrick M Brunner, et al.American Journal of Clinical Dermatology|April 17, 2026
Identifying the Most Relevant Eczema Area and Severity Index Thresholds from the Patient Perspective in Atopic Dermatitis TreatmentLawrence F Eichenfield, Peter A Lio, Alan D Irvine, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2019
Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey-based position statementY A Leshem, R Bissonnette, C Paul, et al.Advances in Therapy|September 5, 2022
A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19Thomas Bieber, Eugen Feist, Alan D Irvine, et al.Cardiovascular Surgery (London, England)|April 1, 1997
Activated protein C resistance, factor V Leiden and peripheral vascular diseaseP W Foley, C D Irvine, G R Standen, et al.Glycoconjugate Journal|September 19, 2007
Distinct contributions of beta 4GalNAcTA and beta 4GalNAcTB to Drosophila glycosphingolipid biosynthesisAnita Stolz, Nicola Haines, Andreas Pich, et al.Development (Cambridge, England)|February 10, 2011
Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian developmentYaopan Mao, Joanna Mulvaney, Sana Zakaria, et al.Orphanet Journal of Rare Diseases|February 28, 2021
Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndromeKarina Forde, Nicoletta Resta, Carlotta Ranieri, et al.Canadian Journal of Nursing Leadership|October 22, 2004
Practice patterns of acute care nurse practitionersS Sidani, D Irvine, H Porter, et al.Clinical and Experimental Dermatology|April 9, 2023
Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitisThomas Bieber, Jacob P Thyssen, Alan D Irvine, et al.Pageof 58